期刊文献+

卵巢癌FIGO分期与血小板计数相关性分析 被引量:4

Correlation between the ovarian cancer FIGO stage and platelet count
下载PDF
导出
摘要 目的探讨血小板计数变化与卵巢癌分期的关系。方法选取2009年1月至2010年8月有明确病理分型及血细胞分析结果的卵巢癌患者74例(其中16例淋巴结转移),并与68例良性卵巢癌患者结果进行比较。结果早期卵巢癌组、晚期卵巢癌组和对照组间PLT计数两两比较差异均有统计学意义(P<0.05)。晚期卵巢癌PLT增多所占比例明显高于早期卵巢癌组,差异有统计学意义(P<0.05)。卵巢癌早、晚期手术前PLT值较高,手术后显著下降(P<0.05)。13例经标准治疗后,由稳定发展至转移的患者,稳定期与转移期血小板值比较差异有统计学意义(P<0.05)。结论卵巢癌常可观察到PLT增多现象,随着分期升高,PLT增高所占比例也随之增加,同时PLT增多可能对卵巢癌发展和转移评估有一定的意义。 Objective The aim of the present study was to investigate the correlation between platelet count and the stage of ovarian cancer(FIGO).Methods Medical records of 74 ovarian cancer patients between January 2009 and August 2010 were reviewed.Clinicopathological and complete blood count data were collected.The results were compared with those of 68 patients with benign ovarian tumor.16 patients who had surgeon have metastasis.Results We found that platelet count in pretreated ovarian cancer patients was distinctively higher than patients with benign ovarian tumor(P0.05),significantly higher in late stage than in early stage(P0.05),and significantly lower after operation than before operation(P0.05).After treatment,13 patients with higher platelet count are easier metastasis than those of normal platelet count.Conclusion Preoperative thrombocytosis is a frequent finding in ovarian cancer and their association with advanced stage disease and higher grade denotes that platelets perhaps play a role in the tumor growth and metastasis.
出处 《国际检验医学杂志》 CAS 2013年第14期1803-1804,共2页 International Journal of Laboratory Medicine
关键词 卵巢肿瘤 血小板计数 肿瘤分期 肿瘤转移 ovarian neoplasms platelet count neoplasm staging neoplasm metastasis
  • 相关文献

参考文献10

  • 1Bambace NM,Holmes CE. The platelet contribution to cancerprogression[J]. Thromb Haemost,2011,9(2) ;237-249.
  • 2Sucak A. The role of thrombocytosis in prognostic evaluation of epithelialovarian tumors[J]. Arch Gynecol Obstet,2009,279(1) : 53-56.
  • 3马爽,童英.妇科恶性肿瘤与血小板增多的关系[J].医学综述,2012,18(10):1489-1492. 被引量:10
  • 4Soonthornthum T, Suraseraneewong V. Thrombocytosis in ad-vanced epithelial ovarian cancer[J]. J Med Assoc Thai,2007,90(8):1495-1500.
  • 5梁致怡,张虹.卵巢上皮性癌和血小板计数增高相关性分析[J].中国肿瘤临床,2008,35(13):729-732. 被引量:4
  • 6Crasta JA,Premlatha TS,Krishnan SM,et al. Significance of pre-operative thrombocytosis in epithelial ovarian cancer[J]. Indian JPathol Microbiol,2010,53(1) :54-56.
  • 7Gastl G,Plante M. Bioactive interleukin-6 levels in serum and as-cites as a prognostic factor in patients with epithelial ovarian canc-er[J]. Methods Mol Med,2001,39(1) : 121-123.
  • 8Borsig L,The role of platelet activation in tumor metastasis[J].Expert Rev Anticancer Ther,2008,8(8) : 1247-1255.
  • 9Gungor T,Tsuruo T,Fujita N. Platelet aggregation in the forma-tion of tumor metastasis [J], Proc Jpn Acad Ser B Phys Biol Sci,2008,84(6):189-198.
  • 10Lee M,Kim SW,Nam EJ,et al. The impact of pretreatment thrombo-cytosis and persistent thrombocytosis after adjuvant chemotherapyin patients with advanced epithelial ovarian cancer [J]. GynecolOncol,2011,122(2) :238-241.

二级参考文献35

共引文献11

同被引文献41

  • 1姚俊阁,李想,岳青芬.白蛋白结合型紫杉醇对二线治疗失败晚期卵巢癌患者血清VEGF、CCL-18水平的影响及安全性分析[J].慢性病学杂志,2021(5):739-741. 被引量:4
  • 2郭翠英,张吟真,朱晓研.p16基因表达在卵巢癌分化程度诊断及化疗疗效判断中的意义[J].诊断学理论与实践,2005,4(3):199-201. 被引量:4
  • 3万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1265
  • 4Varki A, Trousseaurs syndrome.multiple definitions and multiple mechanisms[J]. Blood, 2007,110(6) .. 1723-1729.
  • 5Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis[J]. Nat Rev Cancer, 2011,11 (2) 123-134.
  • 6Palumbo JS,Degen JL. Mechanisms linking tumor cell-as- sociated procoagulant function to tumor metastasts[J]. Thromb Res,2007,120(Suppl 2) zS22-28.
  • 7Hu L, Roth JM, Brooks PI, et al. Twist is required for thrombin-induced tumor angiogenesis and growth [J]. Cancer Res, 2008,68 (11) .. 4296-4302.
  • 8Maynard DM, Heijnen HF, Horne MK,et al. Proteomic a- nalysis of platelet alpha-granules using mass spectrometry [J]. J Thromb Haemost,2007,5(9) : 1945-1955.
  • 9Pfistershammer K, Majdic O, St6ckl J, et al. CD63 as an activation-linked T cell eostimulatory element[J]. J Im- munol, 2004,173 (10) : 6000-6008.
  • 10Battinelli EM, Markens BA, Italiano JE Jr. Release of an- giogenesis regulatory proteins from platelet alpha gran- ules:modulation of physiologic and pathologic angiogene- sis[J]. Blood, 2011,118(5) : 1359-1369.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部